Clinical Trial Update: Contact Lenses With New UV-blocker Manufactured With Different Techniques [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on contact lenses with a new UV-blocker produced using different manufacturing techniques; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attenuation of Bright Light
• Correction of Refractive Error

Drugs mentioned

• Johnson & Johnson Vision Care, Inc. contact lenses with UV-blocker

Snippet

Sponsor: Johnson & Johnson Vision Care, Inc. | Conditions: Correction of Refraction Error, Attenuation of Bright Light | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-06-04